<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01033201</url>
  </required_header>
  <id_info>
    <org_study_id>08-000800</org_study_id>
    <secondary_id>ACA00001534</secondary_id>
    <nct_id>NCT01033201</nct_id>
  </id_info>
  <brief_title>Alveoscopy, Endoscopic Confocal Microscopy and Lung Rejection, Parenchymal Lung Diseases in Vivo</brief_title>
  <official_title>The Role Of Endoscopic Alveoscopy by Confocal Endomicroscopy in Diagnosing Acute and Chronic Rejection in Lung Transplant Recipients, Diagnosis of End Stage Lung Disease, and Other Pulmonary Pathologies in Vivo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lung transplantation is indicated when end-stage lung diseases no longer respond to available
      standard therapy, making life expectancy short and associated with disability. Acute and
      chronic rejection are common complications following transplantation, indicating screening
      bronchoscopies and transbronchial biopsies at three month intervals the first two years, in
      addition to clinically indicated procedures when rejection or infection is suspected.
      Transbronchial biopsies carry associated risks (bleeding, pneumothorax). Chronic rejection is
      characterized by progressive obliteration of distal airways (Bronchiolitis Obliterans-BO-).
      BO requires open lung biopsy for diagnosis. Alternatively, a clinical surrogate
      (Bronchiolitis Obliterans Syndrome), characterized by decline in Forced Expired Volume in 1
      second not explained by acute rejection or infection is used for diagnosis. The new technique
      of confocal endo-microscopy enables sub-surface visualization of tissue in vivo during
      bronchoscopic procedures using a probe-based confocal microscope, integrated to a standard
      endoscope. Bronchiolar and alveolar structures can be visualized at a cellular and nuclear
      level, and these images can be saved and reviewed. This new technology could potentially
      identify acute and chronic rejection, thus offering and alternative to transbronchial
      biopsies. We expect to describe a new alternative to diagnose acute and chronic rejection
      using confocal microscopy images obtained endoscopically, obviating complications of
      transbronchial biopsies.

      Endoscopic confocal endomicroscopy can detect and classify common bronchiolar and alveolar
      pathological conditions in real time. Specifically, we hypothesize that confocal
      endomicroscopy images of bronchiolar and alveolar structures during standard bronchoscopy
      could help to recognize and classify the presence/absence of acute rejection and/or
      bronchiolitis obliterans syndrome in lung transplant recipients. This technology could also
      identify the histological characteristics lung diseases such as interstitial, obstructive or
      vascular end stage lung diseases, and thus lead to more efficient, safer and more accurate
      diagnosis of these lung conditions during routine bronchoscopies.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To determine in an unblinded study, the key image features of acute lung rejection and chronic lung rejection (BOS), and estimate which morphologic features best distinguish these conditions.</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine the initial sensitivity and specificity of confocal imaging for the classification of acute lung rejection among lung transplant recipients.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To develop a library of confocal images with the most optimal confocal imaging characteristics of other lung pathologies requiring lung transplantation.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine the inter-examiner differences and learning curve for accurate detection of acute rejection as well as the confocal images of other lung pathologies.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine in a unblinded pilot study, the key image features of chronic lung rejection as defined by the Bronchiolitis Obliterans Syndrome (BOS), and estimate which morphologic features best distinguish this conditions.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">71</enrollment>
  <condition>Lung Transplant</condition>
  <arm_group>
    <arm_group_label>Lung transplant</arm_group_label>
    <description>All lung transplant patients presenting for screening/surveillance and diagnostic bronchoscopies at Mayo Clinic Florida are eligible for participation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Confocal imaging</intervention_name>
    <description>At the time of the standard of care bronchoscopy, confocal images will be obtained from each consented patient.</description>
    <arm_group_label>Lung transplant</arm_group_label>
    <other_name>AlveoloFlex Confocal Miniprobes</other_name>
    <other_name>Cellvizio-Lung system</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled to undergo bronchoscopy either before or after lung transplantation.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age above 18 years

          2. Any patient undergoing surveillance or clinically indicated bronchoscopies during or
             after lung transplantation

          3. Any patient undergoing bronchoscopy prior lung transplant

        Exclusion Criteria:

          1. Unwilling to consent

          2. Unable to safely tolerate a bronchoscopic procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mayo Clinic Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>St Croix CM, Leelavanichkul K, Watkins SC. Intravital fluorescence microscopy in pulmonary research. Adv Drug Deliv Rev. 2006 Sep 15;58(7):834-40. Epub 2006 Aug 11.</citation>
    <PMID>16996641</PMID>
  </reference>
  <reference>
    <citation>Herth FJ, Eberhardt R, Ernst A. The future of bronchoscopy in diagnosing, staging and treatment of lung cancer. Respiration. 2006;73(4):399-409. Review.</citation>
    <PMID>16775411</PMID>
  </reference>
  <reference>
    <citation>Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, Dobbels F, Rahmel AO, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant. 2007 Aug;26(8):782-95. Review.</citation>
    <PMID>17692782</PMID>
  </reference>
  <reference>
    <citation>Moffatt SD, Demers P, Robbins RC, Doyle R, Wienacker A, Henig N, Theodore J, Reitz BA, Whyte RI. Lung transplantation: a decade of experience. J Heart Lung Transplant. 2005 Feb;24(2):145-51.</citation>
    <PMID>15701428</PMID>
  </reference>
  <reference>
    <citation>Sibley RK, Berry GJ, Tazelaar HD, Kraemer MR, Theodore J, Marshall SE, Billingham ME, Starnes VA. The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant. 1993 Mar-Apr;12(2):308-24.</citation>
    <PMID>8476904</PMID>
  </reference>
  <reference>
    <citation>Bowdish ME, Arcasoy SM, Wilt JS, Conte JV, Davis RD, Garrity ER, Hertz ML, Orens JB, Rosengard BR, Barr ML. Surrogate markers and risk factors for chronic lung allograft dysfunction. Am J Transplant. 2004 Jul;4(7):1171-8. Review.</citation>
    <PMID>15196078</PMID>
  </reference>
  <reference>
    <citation>Colombat M, Groussard O, Lautrette A, Thabut G, Marrash-Chahla R, Brugière O, Mal H, Lesèche G, Fournier M, Degott C. Analysis of the different histologic lesions observed in transbronchial biopsy for the diagnosis of acute rejection. Clinicopathologic correlations during the first 6 months after lung transplantation. Hum Pathol. 2005 Apr;36(4):387-94.</citation>
    <PMID>15892000</PMID>
  </reference>
  <reference>
    <citation>Khalifah AP, Hachem RR, Chakinala MM, Yusen RD, Aloush A, Patterson GA, Mohanakumar T, Trulock EP, Walter MJ. Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant. 2005 Aug;5(8):2022-30.</citation>
    <PMID>15996255</PMID>
  </reference>
  <reference>
    <citation>Hachem RR, Yusen RD, Chakinala MM, Meyers BF, Lynch JP, Aloush AA, Patterson GA, Trulock EP. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. J Heart Lung Transplant. 2007 Oct;26(10):1012-8.</citation>
    <PMID>17919621</PMID>
  </reference>
  <reference>
    <citation>Tazelaar HD, Nilsson FN, Rinaldi M, Murtaugh P, McDougall JC, McGregor CG. The sensitivity of transbronchial biopsy for the diagnosis of acute lung rejection. J Thorac Cardiovasc Surg. 1993 Apr;105(4):674-8.</citation>
    <PMID>8469001</PMID>
  </reference>
  <reference>
    <citation>Yousem SA, Berry GJ, Cagle PT, Chamberlain D, Husain AN, Hruban RH, Marchevsky A, Ohori NP, Ritter J, Stewart S, Tazelaar HD. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant. 1996 Jan;15(1 Pt 1):1-15.</citation>
    <PMID>8820078</PMID>
  </reference>
  <reference>
    <citation>Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002 Mar;21(3):297-310. Review.</citation>
    <PMID>11897517</PMID>
  </reference>
  <reference>
    <citation>Kiesslich R, Burg J, Vieth M, Gnaendiger J, Enders M, Delaney P, Polglase A, McLaren W, Janell D, Thomas S, Nafe B, Galle PR, Neurath MF. Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology. 2004 Sep;127(3):706-13.</citation>
    <PMID>15362025</PMID>
  </reference>
  <reference>
    <citation>Thiberville L, Moreno-Swirc S, Vercauteren T, Peltier E, Cavé C, Bourg Heckly G. In vivo imaging of the bronchial wall microstructure using fibered confocal fluorescence microscopy. Am J Respir Crit Care Med. 2007 Jan 1;175(1):22-31. Epub 2006 Oct 5.</citation>
    <PMID>17023733</PMID>
  </reference>
  <reference>
    <citation>Pacurariu RI. Low incidence of side effects following intravenous fluorescein angiography. Ann Ophthalmol. 1982 Jan;14(1):32-6.</citation>
    <PMID>7125438</PMID>
  </reference>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2009</study_first_submitted>
  <study_first_submitted_qc>December 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2009</study_first_posted>
  <last_update_submitted>January 25, 2012</last_update_submitted>
  <last_update_submitted_qc>January 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2012</last_update_posted>
  <responsible_party>
    <name_title>Cesar A. Keller, M.D.</name_title>
    <organization>Mayo Clinic Florida</organization>
  </responsible_party>
  <keyword>Lung rejection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

